Filing Details
- Accession Number:
- 0001021771-24-000091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-10 17:16:36
- Reporting Period:
- 2024-04-08
- Accepted Time:
- 2024-04-10 17:16:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505497 | Biorestorative Therapies Inc. | BRTX | Services-Misc Health & Allied Services, Nec (8090) | 301341024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1527241 | Francisco Silva | C/O Biorestorative Therapies, Inc. 40 Marcus Drive Melville NY 11747 | Vp Of Research And Development | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-08 | 476 | $1.13 | 147,927 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-08 | 1,232 | $1.17 | 149,159 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-09 | 6,600 | $1.25 | 155,759 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,136 | Indirect | IRA |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | $3,000.00 | 2024-10-23 | 9 | 9 | Direct | |
| Common Stock | Stock Option | $3,000.00 | 2025-09-04 | 6 | 6 | Direct | |
| Common Stock | Stock Option | $3,000.00 | 2026-06-10 | 15 | 15 | Direct | |
| Common Stock | Stock Option | $3,000.00 | 2027-07-12 | 20 | 20 | Direct | |
| Common Stock | Stock Option | $3,000.00 | 2028-10-29 | 25 | 25 | Direct | |
| Common Stock | Stock Option | $5.08 | 2031-03-18 | 293,479 | 293,479 | Direct | |
| Common Stock | Stock Option | $5.08 | 2031-11-04 | 42,059 | 42,059 | Direct | |
| Common Stock | Stock Option | $2.91 | 2033-02-17 | 106,762 | 106,762 | Direct | |
| Common Stock | Stock Option | $1.45 | 2034-02-13 | 394,737 | 394,737 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-10-23 | 9 | 9 | Direct |
| 2025-09-04 | 6 | 6 | Direct |
| 2026-06-10 | 15 | 15 | Direct |
| 2027-07-12 | 20 | 20 | Direct |
| 2028-10-29 | 25 | 25 | Direct |
| 2031-03-18 | 293,479 | 293,479 | Direct |
| 2031-11-04 | 42,059 | 42,059 | Direct |
| 2033-02-17 | 106,762 | 106,762 | Direct |
| 2034-02-13 | 394,737 | 394,737 | Direct |
Footnotes
- The option is currently exercisable.
- The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
- The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
- The option vests and becomes exercisable to the extent of 197,369 shares on February 13, 2024 and 197,368 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.
Billionaire Hedge Funds
